Revolutionizing Breast Imaging: Rezolut Launches SecondReadAI(TM), powered by Lunit
ATLANTA, GA / ACCESSWIRE / August 28, 2024 / Rezolut, LLC, a pioneering leader in medical imaging technology, has unveiled...
Cancer
Rutherrin(R) Increases Efficacy of Chemotherapy for Lung Cancer
TORONTO, ON / ACCESSWIRE / August 28, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Correction: Cantargia Publishes Half-Year Report 2024
Correction of sign on three values in the Changes in working capital on page 16 of the report. Corrected values...
HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
NEW YORK and VIENNA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a company...
IMUNON to Host R&D Day on September 18th
R&D Discussion in New York City to Review IL-12’s Potential to Treat Ovarian Cancer Program Features Ovarian Cancer Thought Leaders,...
Mestag Therapeutics Awarded Significant Grant from Innovate UK’s Prestigious Cancer Therapeutics Program to Accelerate the Path to the Clinic for MST-0300
Mestag Therapeutics Employees of Cambridge, UK based Mestag Therapeutics - Innovate UK, part of UK Research and Innovation, is investing...
Tribun Health Partners With Ibex to Deliver Advanced AI Diagnostic Solutions
ARIS, FRANCE AND MONTREAL, QUEBEC / ACCESSWIRE / August 28, 2024 / Tribun Health, a leading provider of digital pathology...
Cantargia Publishes Half-Year Report 2024
LUND, SE / ACCESSWIRE / August 28, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced its...
AI-based Medical Device Company Imidex and Precision Genomix Company Orbit Genomics Form Strategic Relationship to Explore the Detection of Lung Cancer in Early Stages
Computer Vision AI and Precision Genomic Collaboration Aims to Increase Early Detection Rates, Improving Survival Chances for Millions DENVER, Aug....
Nova Mentis Assigns Intellectual Property
Vancouver, British Columbia--(Newsfile Corp. - August 27, 2024) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)...
RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New York
LOS ALTOS, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical...
Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference
THE WOODLANDS, TX, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical...
Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters
The Congresswoman representing Georgia’s 7th district in the U.S. House of Representatives toured Femasys’ facilities to gain a better understanding...
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms
Figure: 1 Elements of Ocean Biomedical Multi-pronged Malaria Program Testing Result Figure: 2 Dr. Jonathan Kurtis conducting research near Kisumu,...
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2024 and Business Update
Exploration and evaluation of strategic alternatives continueWESTPORT, Conn., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the...
Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery
Study further validates highly reproducible drug response data. Enables AI platform to model and predict patient outcomes on historical samples Global...
myTomorrows and Pancreatic Cancer Europe Partner to Support Pancreatic Cancer Patients in Accessing Clinical Trials
Partnership with the European patient advocacy group furthers myTomorrows' mission to expand access to all possible treatment options for patients...
Cantargia Reports Timelines for Nadunolimab Clinical Trials in Leukemia and Triple Negative Breast Cancer
LUND, SE / ACCESSWIRE / August 27, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported currently...
Spago Nanomedical’s Phase I/IIa Study Tumorad-01 Continues Following Successful Treatment Completion of First Patient Group
LUND, SE / ACCESSWIRE / August 27, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) today announced that the...
Beyond Medals: The Toughest Discipline is Overcoming Daily Disability Barriers
Ottobock Launches Paralympic Games Initiative: ‘The Unofficial Discipline'BURLINGTON, ON / ACCESSWIRE / August 26, 2024 / As the world gathers...